EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
EIDX
Delisted
EIDX was delisted on the 25th of January, 2021.
89 hedge funds and large institutions have $617M invested in Eidos Therapeutics, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 30 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
89
Holders Change
-13
Holders Change %
-12.75%
% of All Funds
1.97%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
13
Increased
29
Reduced
30
Closed
26
Calls
$5.4M
Puts
$4.34M
Net Calls
+$1.06M
Net Calls Change
-$9.77M
Top Buyers
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$29.6M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$10.4M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$8.07M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$4.77M |
| 5 |
BlackRock
New York
|
+$4.59M |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$10.4M |
| 2 |
Holocene Advisors
New York
|
-$9.62M |
| 3 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$6.18M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$3.49M |
| 5 |
CAC
Cowen and Company
New York
|
-$2.69M |
